ISSN: 2165-7025

Zeitschrift für neuartige Physiotherapien

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Effect to the Synergistic Action of Photobiomodulation and Therapeutic Ultrasound on Psoriatic Arthritis and Fibromyalgia - Case Report

Ana Carolina Negraes Canelada, Vanessa Garcia, Tiago Zuccolotto Rodrigues, Viviane Brocca de Souza, Vitor Hugo Panhoca, Antonio Eduardo de Aquino Junior, Vanderlei Salvador Bagnato

Psoriasis is a chronic inflammatory, autoimmune disease that affects the skin, and over time, can also affect the joints, evolving into psoriatic arthritis. The pathogenesis is related to genetic conditions and etiopathogenic mechanisms, which affect about 2% of the world population. In the aspect of psoriatic arthritis, the chronic peripheral inflammatory process affects the joints, bones and muscles, generating hyperalgesia and allodynia. This process can lead to the development of fibromyalgia, which is a chronic disease with generalized muscle pain, related by genetic and psychosocial factors and concomitant diseases, such as psoriatic arthritis. In this study, the synergistic interaction of photobiomodulation and therapeutic ultrasound was used in a picture of associated diseases of psoriasis, psoriatic arthritis and fibromyalgia. In the evaluation mechanism, the Fibromyalgia Impact Questionnaire (FIQ), Quality of Life in Psoriatic Arthritis (PsAQoL) and the Visual Analogue Scale (VAS) were used. It was observed, in a period of 14 sessions, that the synergistic action of photobiomodulation and therapeutic ultrasound, presented benefits and improvement in the patient's quality of life (FIQ and PsAQoL), as well as pain reduction (VAS).